NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NuGEN Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5333
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA and RNA, target capture, ChIP-Seq, and Methyl-Seq, Microarrays and qPCR, and bioinformatics and automation software solutions, among others. NuGen’s next generation technologies are used in the areas of cancer detection, infectious disease, liquid biopsy, agrigenomics, microbiomics and epigenetics, among others. The company markets its products through a network of distributors located across the US, Australia, the Netherlands, South Korea, Canada, China, Spain and Hong Kong, among others. It operates in San Carlos, the US and Leek, the Netherlands. NuGEN is headquartered in San Carlos, California, the US.

NuGEN Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NuGEN Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NuGEN Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
NuGEN Technologies Raises USD6.2 Million in Venture Financing 11
Partnerships 12
NuGEN Technologies Enters into Agreement with Cambridge Epigenetix 12
Acquisition 13
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 13
NuGEN Technologies Inc – Key Competitors 14
NuGEN Technologies Inc – Key Employees 15
NuGEN Technologies Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Legal and Regulatory 17
Aug 13, 2018: NuGEN and KeyGene announce settlement in declaratory judgment lawsuit 17
Product News 18
Oct 02, 2017: NuGEN Introduces Unique Indexing Solutions for Illumina’s High Capacity Sequencing Platforms 18
Other Significant Developments 19
Jan 31, 2017: NuGEN Continues with Investment Across Worldwide Territories 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NuGEN Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NuGEN Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
NuGEN Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NuGEN Technologies Raises USD6.2 Million in Venture Financing 11
NuGEN Technologies Enters into Agreement with Cambridge Epigenetix 12
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 13
NuGEN Technologies Inc, Key Competitors 14
NuGEN Technologies Inc, Key Employees 15

List of Figures
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NuGEN Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NuGEN Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Numaligarh Refinery Ltd:企業の戦略的SWOT分析
    Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野:企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • Advanced Biological Laboratories SA-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Shandong Weigao Group Medical Polymer Company Ltd (1066):医療機器:M&Aディール及び事業提携情報
    Summary Shandong Weigao Group Medical Polymer Company Ltd (Weigao) researches, develops, manufactures and sells disposable medical consumables, orthopedic materials and blood purification products. Its products include infusion sets, needles, blood bags, heart eluting stents, blood sampling products …
  • US Foods Holding Corp. (USFD):企業の財務・戦略的SWOT分析
    US Foods Holding Corp. (USFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical serv …
  • CLAAS KGaA mbH:企業の戦略的SWOT分析
    CLAAS KGaA mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Leidos Holdings Inc:企業のM&A・事業提携・投資動向
    Leidos Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leidos Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • RainDance Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; …
  • Inova Health System:製薬・医療:M&Aディール及び事業提携情報
    Summary Inova Health System (Inova) is a non-profit health care system operating through multiple hospitals. It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others. Through a network of ho …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務分析
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析
    Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bankinter, S.A.:企業のM&A・事業提携・投資動向
    Bankinter, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankinter, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Histogen Inc-医療機器分野:企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …
  • Invenergy LLC:企業の発電所・SWOT分析2018
    Invenergy LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Loblaw Companies Limited:戦略・SWOT・企業財務分析
    Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report Summary Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …
  • OMV New Zealand Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary OMV New Zealand Ltd (OMV NZ) a subsidiary of OMV AG, is an oil and natural gas exploration and production company. It offers upstream production services with offshore oil and gas fields in Maari, Pohokura, and Maui across Taranaki coast, Tunisia and in the Black Sea. The company operates ex …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆